Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses-Reference-Cited by-同舟云学术

Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses

Published:2015-02-27 Issue:2 Volume:11 Page:e1004658
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Hancock Gemma,Yang Hongbing,Yorke Elisabeth,Wainwright Emma,Bourne Victoria,Frisbee Alyse,Payne Tamika L.,Berrong Mark,Ferrari Guido,Chopera Denis,Hanke Tomas,Mothe Beatriz,Brander Christian,McElrath M. Juliana,McMichael Andrew,Goonetilleke Nilu,Tomaras Georgia D.,Frahm Nicole,Dorrell Lucy

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference66 articles.

1. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;SP Buchbinder;Lancet,2008

2. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis;MJ McElrath;Lancet,2008

3. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine;SM Hammer;N Engl J Med,2013

4. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge;NA Wilson;J Virol,2009

5. Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles;SA Migueles;PLoS Pathog,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses;Vaccines;2024-03-07

2. Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions;Scientific Reports;2023-10-11

3. Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial;Nature Medicine;2022-10-27

4. CD8 T Cell Virus Inhibition Assay Protocol;BIO-PROTOCOL;2022

5. Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers;Frontiers in Immunology;2021-12-23